Pfizer Inc.
PFENYSE
$30.28
Last price · USD
- Market cap
- $172.2B
- P/E
- 22.3x
- EV / EBITDA
- 14.2x
- P/S
- 2.8x
- FCF yield
- 5.3%
- Div. yield
- 5.68%
Multiples use last price and FY2025 annual figures. Market cap estimated from diluted shares.
Pfizer Inc. cash flow statement
Annual · USD millions except per-share data · 36 lines
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 | CAGR | |
|---|---|---|---|---|---|---|---|
| Operating activities | |||||||
| Net income | 7,787 | 8,051 | 2,173 | 31,401 | 22,459 | -23.3% | |
| Depreciation & amortization | 6,592 | 7,013 | 6,290 | 5,064 | 5,191 | +6.2% | |
| Deferred income tax | (2,133) | (2,102) | (3,442) | (3,764) | (4,293) | — | |
| Stock-based compensation | 799 | 877 | 525 | 872 | 1,182 | -9.3% | |
| Change in working capital | (5,354) | (3,066) | (2,172) | (4,456) | 12,804 | — | |
| Accounts receivables | (263) | (109) | 347 | 261 | (3,811) | — | |
| Inventory | 561 | (854) | (1,169) | 592 | (1,125) | — | |
| Accounts payables | (469) | (1,023) | (300) | 1,191 | 1,242 | — | |
| Other working capital | (5,183) | (1,080) | (1,050) | (6,500) | 16,498 | — | |
| Other non-cash items | 4,013 | 1,971 | 5,326 | 150 | (4,763) | — | |
| Net cash from operating activities | 11,705 | 12,744 | 8,700 | 29,267 | 32,580 | -22.6% | |
| Operating cash flow | 11,705 | 12,744 | 8,700 | 29,267 | 32,580 | -22.6% | |
| Investing activities | |||||||
| Investments in PP&E | (2,629) | (2,909) | (3,907) | (3,236) | (2,711) | — | |
| Capital expenditure | (2,629) | (2,909) | (3,907) | (3,236) | (2,711) | — | |
| Acquisitions, net | (6,927) | 7,040 | (43,430) | (22,997) | (12) | — | |
| Purchases of investments | (14,650) | (10,313) | (31,178) | (38,780) | (47,613) | — | |
| Sales / maturities of investments | 22,690 | 8,834 | 46,417 | 45,462 | 28,096 | -5.2% | |
| Other investing activities | 165 | 0 | (180) | 3,768 | (306) | — | |
| Net cash from investing activities | (1,351) | 2,652 | (32,278) | (15,783) | (22,546) | — | |
| Financing activities | |||||||
| Net debt issuance | (74) | (7,159) | 35,945 | (3,516) | (1,103) | — | |
| Short-term net debt issuance | (2,995) | (4,909) | 7,683 | (218) | (96) | — | |
| Long-term net debt issuance | 2,921 | (2,250) | 28,262 | (3,298) | (1,007) | — | |
| Net stock issuance | 0 | 0 | 0 | (2,000) | 0 | — | |
| Common stock repurchased | 0 | 0 | 0 | (2,000) | 0 | — | |
| Net common stock issuance | 0 | 0 | 0 | (2,000) | 0 | — | |
| Common dividends paid | (9,771) | (9,512) | (9,247) | (8,983) | (8,729) | — | |
| Net dividends paid | (9,771) | (9,512) | (9,247) | (8,983) | (8,729) | — | |
| Other financing activities | (459) | (469) | (632) | (335) | 16 | — | |
| Net cash from financing activities | (10,304) | (17,140) | 26,066 | (14,834) | (9,816) | — | |
| Cash summary | |||||||
| Effect of forex changes on cash | 49 | (66) | (40) | (165) | (60) | — | |
| Net change in cash | 99 | (1,810) | 2,449 | (1,515) | 158 | -11.0% | |
| Cash at beginning of period | 1,043 | 2,917 | 468 | 1,983 | 1,825 | -13.1% | |
| Cash at end of period | 1,142 | 1,107 | 2,917 | 468 | 1,983 | -12.9% | |
| Free cash flow | 9,076 | 9,835 | 4,793 | 26,031 | 29,869 | -25.8% | |
| Income taxes paid | 0 | 3,605 | 3,147 | 7,867 | 7,427 | — | |
| Interest paid | 2,739 | 3,227 | 2,215 | 1,442 | 1,467 | +16.9% | |